Search | IOVS | ARVO Journals

Showing 1 – 20 of 119

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Detection of premyopic and early myopic levels of refractive error in children using QuickSee wavefront autorefraction

Anh Bui; Marjean T Kulp; G.Lynn Mitchell

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5189.

ARVO Annual Meeting Abstract June 2025

A Phase 1B Multiple Ascending Dose Study of VP-001; a peptide conjugate of oligonucleotide designed to treat PRPF31-related Retinitis Pigmentosa

Lesley A Everett; John Chancellor; Sandeep Grover; Thiran Jayasundera; Byron L Lam; Mark Pennesi; George Mitchell; Clare Guerrero; Naveed Shams; Sri Mudumba

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):6396.

ARVO Annual Meeting Abstract June 2025

LYNX-1 Phase 3 trial of the safety and efficacy of phentolamine ophthalmic solution for the treatment of reduced mesopic low contrast vision: A subset analysis of keratorefractive subjects

Kostas Charizanis; Marguerite McDonald; Stephen M Montaquila; Drey Coleman; Mitchell G Brigell; Jay Stuart Pepose

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):173.

ARVO Annual Meeting Abstract June 2024

Prescribing Patterns for Children with Astigmatism

Marjean T Kulp; Elise Ciner; G. Lynn Mitchell; Gui-Shuang Ying; Ann Morrison; David Granet; Tawna L Roberts; Mae Millicent Peterseim; T Rowan Candy; Christine Allison; Sandra S Block; Bruce Moore; Deborah Orel-Bixler; Shira Robbins; Gayathri Srinivasan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5217.

ARVO Annual Meeting Abstract June 2024

Oral APX3330, a Ref-1 Inhibitor, Slows Progression of Diabetic Retinopathy on a Binocular DRSS Person-Level Scale

Daniel Su; Jay Stuart Pepose; Barbara Withers; Mitchell G Brigell; Audrey Lazar; Ronil Patel; George Magrath; Peter K Kaiser; David S Boyer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):958.

Refractive Intervention September 2023

Visual Acuity Prediction Based on Different Refraction Types For Patients With Down Syndrome

PDF

Lauren V. Schneider; G. Lynn Mitchell; Jason D. Marsack; Heather A. Anderson
TAGS: down syndrome, image quality, refraction, visual acuity
Trans. Vis. Sci. Tech.. 2023; 12(9):11. https://doi.org/10.1167/tvst.12.9.11

ARVO Annual Meeting Abstract June 2023

Visual acuity prediction based on refraction type for patients with Down syndrome

Lauren Schneider; G.Lynn Mitchell; Jason D Marsack; Heather A Anderson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1483.

ARVO Annual Meeting Abstract June 2023

Effect of Co-existing Clinical Signs on Prescribing Patterns for Pediatric Hyperopia

Ann Morrison; Marjean T Kulp; Elise B. Ciner; Catherine McDaniel; G.Lynn Mitchell; Christine L. Allison; Sandra S Block; David Granet; Richard W Hertle; Bruce Moore; Deborah Orel-Bixler; Tawna L Roberts; Shira L Robbins; M.Millicent Peterseim; Gayathri Srinivasan; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1463.

ARVO Annual Meeting Abstract June 2023

One-year Outcome in a Randomized Clinical Trial of Treatment for Symptomatic Convergence Insufficiency in Children (CITT-ART)

Marjean T Kulp; Ann Morrison; G.Lynn Mitchell; Mitchell Scheiman; Susan A Cotter; Erin Jenewein; Eric Borsting; Richard W Hertle; Annette Bade

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1459.

ARVO Annual Meeting Abstract June 2023

Detection of Significant Vision Conditions in School-age Children using QuickSee Wavefront Auto-refractor

Anh Bui; G.Lynn Mitchell; Marjean T Kulp

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1440.

ARVO Annual Meeting Abstract June 2023

ZETA-1 Phase 2 Trial to Determine the Safety and Efficacy of APX3330: a Novel, Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy

Daniel Su; Jay Stuart Pepose; Mark R Kelley; Audrey Lazar; Louis Haddad; Mina Sooch; Mitchell G Brigell; Peter K Kaiser; David S Boyer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3753.

ARVO Annual Meeting Abstract June 2023

LYNX-1: A Phase 3 Randomized Placebo-Controlled Trial of Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances

Jay Stuart Pepose; Louis Haddad; Audrey Lazar; Mina Sooch; Mitchell G Brigell

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2506.

ARVO Annual Meeting Abstract June 2023

Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trial

Mina Sooch; Jay Stuart Pepose; Louis Haddad; Amar Khatri; Audrey Lazar; Drey Coleman; Mitchell G Brigell

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3099.

ARVO Annual Meeting Abstract June 2023

VEGA-1 Phase 2 Trial: Phentolamine Ophthalmic Solution Maintains Pupillary Light Reflex with Improved Distance-Corrected Near Vision in Presbyopes

Ronil Patel; Mitchell G Brigell; Jay Stuart Pepose; Louis Haddad; Drey Coleman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2507.

ARVO Annual Meeting Abstract June 2023

Phentolamine Ophthalmic Solution, with and without Low Dose Pilocarpine, Provides Durable Improvement in Distance Corrected Near Vision in Presbyopic Patients: A Responder Analysis

Mitchell G Brigell; Jay Stuart Pepose; Kavon Rahmani; Louis Haddad; Mina Sooch

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5423.

ARVO Annual Meeting Abstract June 2023

Riboflavin Ophthalmic Solution activated in situ with a novel scanning laser-based bioactivation system, the NXL UV-A device, demonstrates safety of corneal cross-linking for the treatment of keratoconus

Valerie Smith; Sebastian B. Heersink; Peter Hersh; Kenneth A. Beckman; George O. Waring; Marco E. Armijo; Mitchell J. Gray; Kimi Luc; Alex Yildizyan; David B Usher; Kerry G. Stephens; Angela C. Kothe; Dale Usner; Terence Koritz; L. Jay Katz; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1675.

ARVO Annual Meeting Abstract June 2022

VEGA-1: Phentolamine Ophthalmic Solution as a Single Agent Improves Distance-Corrected Near Visual Acuity in Patients with Presbyopia

James Katz; Eliot Lazar; Ajay Kolli; Ronil Patel; Kavon Rahmani; Mina Sooch; Mitchell G Brigell; Jay Stuart Pepose

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1813 – F0429.

ARVO Annual Meeting Abstract June 2022

The Efficacy of Phentolamine Ophthalmic Solution and Low-Dose Pilocarpine to Improve Distance-Corrected Intermediate Visual Acuity in Patients with Presbyopia

Jay Stuart Pepose; Ajay Kolli; Ronil Patel; Kavon Rahmani; Mina Sooch; Mitchell G Brigell; Eliot Lazar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1809 – F0425.

Articles December 2021

Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION

PDF

Mary A. Johnson; Zara Mehrabian; Yan Guo; Joy Ghosh; Mitchell G. Brigell; Steven L. Bernstein
TAGS: antibodies, eye, neuroprotection, nonarteritic anterior ischemic optic neuropathy, optic nerve, evoked potentials, visual, inflammation, immunohistochemistry, axon
Trans. Vis. Sci. Tech.. 2021; 10(14):12. https://doi.org/10.1167/tvst.10.14.12

ARVO Annual Meeting Abstract June 2021

Prescribing Patterns for Hyperopia

Marjean T Kulp; Elise B Ciner; G. Lynn Mitchell; Gui-Shuang Ying; Mae Millicent Peterseim; Anastasia Alex; Christine Allison; Sandra Block; T Rowan Candy; David Granet; Richard W Hertle; Bruce Moore; Deborah A Orel-Bixler; Tawna L Roberts; Shira Robbins; Gayathri Srinivasan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):137.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Detection of premyopic and early myopic levels of refractive error in children using QuickSee wavefront autorefraction

A Phase 1B Multiple Ascending Dose Study of VP-001; a peptide conjugate of oligonucleotide designed to treat PRPF31-related Retinitis Pigmentosa

LYNX-1 Phase 3 trial of the safety and efficacy of phentolamine ophthalmic solution for the treatment of reduced mesopic low contrast vision: A subset analysis of keratorefractive subjects

Prescribing Patterns for Children with Astigmatism

Oral APX3330, a Ref-1 Inhibitor, Slows Progression of Diabetic Retinopathy on a Binocular DRSS Person-Level Scale

Visual Acuity Prediction Based on Different Refraction Types For Patients With Down Syndrome

Visual acuity prediction based on refraction type for patients with Down syndrome

Effect of Co-existing Clinical Signs on Prescribing Patterns for Pediatric Hyperopia

One-year Outcome in a Randomized Clinical Trial of Treatment for Symptomatic Convergence Insufficiency in Children (CITT-ART)

Detection of Significant Vision Conditions in School-age Children using QuickSee Wavefront Auto-refractor

ZETA-1 Phase 2 Trial to Determine the Safety and Efficacy of APX3330: a Novel, Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy

LYNX-1: A Phase 3 Randomized Placebo-Controlled Trial of Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances

Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trial

VEGA-1 Phase 2 Trial: Phentolamine Ophthalmic Solution Maintains Pupillary Light Reflex with Improved Distance-Corrected Near Vision in Presbyopes

Phentolamine Ophthalmic Solution, with and without Low Dose Pilocarpine, Provides Durable Improvement in Distance Corrected Near Vision in Presbyopic Patients: A Responder Analysis

Riboflavin Ophthalmic Solution activated in situ with a novel scanning laser-based bioactivation system, the NXL UV-A device, demonstrates safety of corneal cross-linking for the treatment of keratoconus

VEGA-1: Phentolamine Ophthalmic Solution as a Single Agent Improves Distance-Corrected Near Visual Acuity in Patients with Presbyopia

The Efficacy of Phentolamine Ophthalmic Solution and Low-Dose Pilocarpine to Improve Distance-Corrected Intermediate Visual Acuity in Patients with Presbyopia

Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION

Prescribing Patterns for Hyperopia

To View More...

You must be signed into an individual account to use this feature.